CORZ
The table below shows Core Scientific, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $311.38M | $836.20M | $50.41M | $15.88M | $970.88K |
| Short-term investments | - | - | - | - | - |
| Receivables | - | $1.02M | - | $234.00K | - |
| Inventory | - | - | - | - | - |
| Total current assets | $895.54M | $903.96M | $97.02M | $85.10M | $1.33M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment |
| $1.29B |
| - |
| - |
| - |
| - |
| Goodwill | - | - | $0.00 | $0.00 | - |
| Total assets | $2.35B | $1.60B | $712.16M | $807.69M | $346.37M |
| Accounts payable | $126.11M | $19.27M | $154.75M | $53.64M | $263.12K |
| Total current liabilities | $781.40M | $134.56M | $488.42M | $186.79M | $4.21M |
| Long-term debt | - | - | - | - | - |
| Total liabilities | $3.31B | $2.42B | $1.31B | $1.22B | $65.58M |
| Retained earnings | -$4.15B | -$3.86B | -$2.42B | -$2.17B | -$64.21M |
| Total equity | -$962.74M | -$943.05M | -$596.94M | -$409.35M | -$64.21M |